Yeongjin Pharm Reports 19% Increase in 1Q Sales... Operating Loss Narrows
[Asia Economy Reporter Ji Yeon-jin] Youngjin Pharmaceutical announced on the 10th that its sales in the first quarter of this year reached 52.3 billion KRW, an increase of 19.9% compared to the same period last year.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
During this period, operating loss decreased by 59.6% to approximately 700 million KRW, and net loss also declined by 18.1% to 1.4 billion KRW.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.